Maine § 24-A §7753 Prohibition of certain discriminatory actions by manufacturer or agent related to 340B entities

Maine Statutes

§ 24-A §7753 — Prohibition of certain discriminatory actions by manufacturer or agent related to 340B entities

Maine § 24-A §7753

Title 24-AMAINE INSURANCE CODE

Ch. 103PROTECT HEALTH CARE FOR RURAL AND UNDERSERVED COMMUNITIES ACT

This text of Maine § 24-A §7753 (Prohibition of certain discriminatory actions by manufacturer or agent related to 340B entities) is published on Counsel Stack Legal Research, covering Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Me. Rev. Stat. tit. 24-A, § 24-A §7753 (2026).

Text

1.Interference with acquisition or delivery of 340B drugs prohibited. A manufacturer or its agent may not deny, restrict, prohibit or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B contract pharmacy on behalf of a 340B entity unless receipt of that 340B drug is prohibited by the United States Department of Health and Human Services.

2.Submission of claims or utilization data prohibited. A manufacturer or its agent may not, either directly or indirectly, require a 340B entity to submit any claims or utilization data as a condition for allowing the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B entity unless the claims or utilization data sharing is required by the United States Departm

Free access — add to your briefcase to read the full text and ask questions with AI

1.
Interference with acquisition or delivery of 340B drugs prohibited.
A manufacturer or its agent may not deny, restrict, prohibit or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B contract pharmacy on behalf of a 340B entity unless receipt of that 340B drug is prohibited by the United States Department of Health and Human Services.
2.
Submission of claims or utilization data prohibited.
A manufacturer or its agent may not, either directly or indirectly, require a 340B entity to submit any claims or utilization data as a condition for allowing the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B entity unless the claims or utilization data sharing is required by the United States Department of Health and Human Services.
3.
Other interference prohibited.
A manufacturer may not otherwise interfere directly or indirectly with a 340B entity unless expressly authorized by the United States Department of Health and Human Services.